NZ271617A - Oral pharmaceutical composition comprising micronized progesterone, poly ethylene glycol and a starch, cellulose pectin or tragacanth excipient - Google Patents

Oral pharmaceutical composition comprising micronized progesterone, poly ethylene glycol and a starch, cellulose pectin or tragacanth excipient

Info

Publication number
NZ271617A
NZ271617A NZ271617A NZ27161794A NZ271617A NZ 271617 A NZ271617 A NZ 271617A NZ 271617 A NZ271617 A NZ 271617A NZ 27161794 A NZ27161794 A NZ 27161794A NZ 271617 A NZ271617 A NZ 271617A
Authority
NZ
New Zealand
Prior art keywords
starch
progesterone
pharmaceutical composition
composition according
estradiol
Prior art date
Application number
NZ271617A
Other languages
English (en)
Inventor
Karen Susanne Gram
Annelise Jensen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of NZ271617A publication Critical patent/NZ271617A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
NZ271617A 1993-08-20 1994-08-19 Oral pharmaceutical composition comprising micronized progesterone, poly ethylene glycol and a starch, cellulose pectin or tragacanth excipient NZ271617A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK93950A DK95093D0 (da) 1993-08-20 1993-08-20 Farmaceutisk formulering indeholdende et hormon

Publications (1)

Publication Number Publication Date
NZ271617A true NZ271617A (en) 1996-11-26

Family

ID=8099329

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ271617A NZ271617A (en) 1993-08-20 1994-08-19 Oral pharmaceutical composition comprising micronized progesterone, poly ethylene glycol and a starch, cellulose pectin or tragacanth excipient

Country Status (17)

Country Link
EP (1) EP0789560A1 (ko)
JP (1) JPH09501682A (ko)
KR (1) KR960703570A (ko)
CN (1) CN1132478A (ko)
AU (1) AU7530594A (ko)
BR (1) BR9407306A (ko)
CA (1) CA2169840A1 (ko)
CZ (1) CZ42596A3 (ko)
DK (1) DK95093D0 (ko)
FI (1) FI960749A (ko)
HU (1) HUT74167A (ko)
LT (1) LT4043B (ko)
NO (1) NO960653D0 (ko)
NZ (1) NZ271617A (ko)
PL (1) PL313113A1 (ko)
SK (1) SK19396A3 (ko)
WO (1) WO1995005807A1 (ko)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2772617B1 (fr) * 1997-12-19 2001-03-09 Besins Iscovesco Lab Comprime de progesterone et son procede de preparation
FR2775599B1 (fr) * 1998-03-09 2001-08-17 Besins Iscovesco Lab Composition pharmaceutique a base de progesterone naturelle de synthese et d'oestradiol et son procede de preparation
GB2339114B (en) * 1998-06-30 2003-03-05 Ericsson Telefon Ab L M Secure messaging in mobile telephones
IL127129A (en) * 1998-11-18 2004-06-01 Ferring Bv Method for preparation of progesterone tablets for vaginal delivery and tablets so prepared
JP4354667B2 (ja) * 1999-08-31 2009-10-28 バイエル・シエーリング・ファーマ・アクチエンゲゼルシャフト 避妊薬としての使用へのエチニルエストラジオールとドロスピレノンの医薬用組合せ
US6544553B1 (en) 1999-12-28 2003-04-08 Watson Pharmaceuticals, Inc. Dosage forms and methods for oral delivery of progesterone
FI20002768A (fi) * 2000-12-18 2002-06-19 Licentia Oy Enteropäällysteisiä lääkekoostumuksia ja niiden valmistus
AU2002242339A1 (en) * 2002-03-14 2003-09-29 Watson Pharmaceuticals, Inc. Progesterone oral drug delivery system
AU2004234057A1 (en) * 2003-04-29 2004-11-11 Akzo Nobel N.V. Antisolvent solidification process
AU2006287925B2 (en) 2005-04-28 2012-03-01 Wyeth Compositions containing micronized tanaproget
EP2055306A1 (de) * 2007-11-05 2009-05-06 Bayer Schering Pharma AG Verwendung eines Gestagens in Kombination mit einem Estrogen und einem oder mehreren pharmazeutisch annehmbaren hilfsstoffen/Trägern zur laktosefreien oralen Kontrazeption
US9375437B2 (en) 2010-06-18 2016-06-28 Lipocine Inc. Progesterone containing oral dosage forms and kits
US20110312928A1 (en) * 2010-06-18 2011-12-22 Lipocine Inc. Progesterone Containing Oral Dosage Forms and Related Methods
US8951996B2 (en) 2011-07-28 2015-02-10 Lipocine Inc. 17-hydroxyprogesterone ester-containing oral compositions and related methods
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
PT2782584T (pt) 2011-11-23 2021-09-02 Therapeuticsmd Inc Preparações e terapias de substituição para hormonoterapias naturais combinadas
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
RU2016143081A (ru) 2014-05-22 2018-06-26 Терапьютиксмд, Инк. Натуральные комбинированные гормонозаместительные составы и терапии
BR112017027688A2 (pt) 2015-06-22 2018-09-04 Lipocine Inc Composições orais que contêm éster de 17- hidroxiprogesterona e métodos relacionados
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3862311A (en) * 1971-04-12 1975-01-21 Ciba Geigy Corp Novel method of enhancing progestational endometrial proliferation with progesterone
FR2408345A1 (fr) 1976-11-30 1979-06-08 Besins Jean Louis Nouvelle composition a action anti-conceptionnelle
GB2091552A (en) 1980-09-09 1982-08-04 Carnrick G W Ltd Use of progesterone for the treatment of post-menopausal women
US4963540A (en) * 1986-04-16 1990-10-16 Maxson Wayne S Method for treatment of premenstrual syndrome
US5084277A (en) 1988-08-30 1992-01-28 Greco John C Vaginal progesterone tablet
US5116619A (en) 1988-08-30 1992-05-26 Lee Roy Morgan Vaginal progesterone tablet
WO1990008537A1 (en) * 1989-02-06 1990-08-09 Abbott Laboratories Pharmaceutical compositions for oral administration
US5223268A (en) * 1991-05-16 1993-06-29 Sterling Drug, Inc. Low solubility drug-coated bead compositions

Also Published As

Publication number Publication date
CA2169840A1 (en) 1995-03-02
DK95093D0 (da) 1993-08-20
NO960653L (no) 1996-02-19
AU7530594A (en) 1995-03-21
KR960703570A (ko) 1996-08-31
LT4043B (en) 1996-09-25
PL313113A1 (en) 1996-06-10
EP0789560A1 (en) 1997-08-20
SK19396A3 (en) 1997-03-05
HU9600376D0 (en) 1996-04-29
HUT74167A (en) 1996-11-28
FI960749A0 (fi) 1996-02-19
BR9407306A (pt) 1996-10-08
FI960749A (fi) 1996-02-19
WO1995005807A1 (en) 1995-03-02
NO960653D0 (no) 1996-02-19
JPH09501682A (ja) 1997-02-18
LT96010A (ko) 1996-06-25
CZ42596A3 (en) 1996-06-12
CN1132478A (zh) 1996-10-02

Similar Documents

Publication Publication Date Title
NZ271617A (en) Oral pharmaceutical composition comprising micronized progesterone, poly ethylene glycol and a starch, cellulose pectin or tragacanth excipient
RU2479306C2 (ru) Фармацевтическая композиция, содержащая тетрагидрофолиевую кислоту
CN1273141C (zh) 包含17β－雌二醇－3－低级链烷酸酯的口服药品和制备方法
JP2638389B2 (ja) 経口投与後のインダパミドの徐放性マトリックス錠剤
NZ586107A (en) Management of breakthrough bleeding in extended hormonal contraceptive regimens
JPH04290829A (ja) 黄体ホルモンのみの避妊薬
AU2021244791B2 (en) Pharmaceutical compositions, method of making and method of using thereof
US5891867A (en) Hormonal medicaments and their use for the correction of oestrogenic deficiencies
CN104706641A (zh) 由一种雌激素化合物和一种保孕化合物组成的激素组合物
JP2000515888A (ja) 経口避妊薬
WO2005117899A1 (en) Pharmaceutical composition comprising tibolone and process for procuding the same
JP2001523639A (ja) プロゲストゲン−抗プロゲストゲンレジメン
US11679114B2 (en) Progestogen-only oral contraception
US20210308155A1 (en) Pharmaceutical compositions, method of making and method of using thereof
CN1950092A (zh) 对延长的激素避孕方案中突破性出血的控制
NZ514895A (en) Use of the anti-progestagen ORG 33245 administrated intermittently with a daily dosage of a progestagen in combined therapy
WO2007009769A1 (en) Oral contraception with trimegestone